The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
[2-amino-4-[[(1S)-1-(2-hydroxyethyl)butyl]amino]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl]-(2-methylthiazol-4-yl)methanone ID: ALA4276988
PubChem CID: 71695973
Max Phase: Preclinical
Molecular Formula: C18H26N6O2S
Molecular Weight: 390.51
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCC[C@@H](CCO)Nc1nc(N)nc2c1CN(C(=O)c1csc(C)n1)CC2
Standard InChI: InChI=1S/C18H26N6O2S/c1-3-4-12(6-8-25)21-16-13-9-24(7-5-14(13)22-18(19)23-16)17(26)15-10-27-11(2)20-15/h10,12,25H,3-9H2,1-2H3,(H3,19,21,22,23)/t12-/m0/s1
Standard InChI Key: NGQVCINKVAWYDL-LBPRGKRZSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
14.5264 -11.9607 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.5253 -12.7802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9402 -11.9571 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.2315 -11.5518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9430 -12.7797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2298 -13.1863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2254 -14.0026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9324 -14.4186 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.6455 -14.0121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6517 -13.1895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2291 -10.7346 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.8174 -13.1886 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.1099 -12.7797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4020 -13.1881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6944 -12.7793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9866 -13.1877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9268 -15.2358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6317 -15.6492 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.2163 -15.6395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4747 -15.3050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9238 -15.9085 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.3275 -16.6191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1280 -16.4545 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.9901 -17.3633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1101 -11.9626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4026 -11.5537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4028 -10.7365 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 6 1 0
5 3 1 0
3 4 2 0
4 1 1 0
5 6 2 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
4 11 1 0
2 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
8 17 1 0
17 18 2 0
17 19 1 0
19 20 2 0
20 21 1 0
21 22 1 0
22 23 2 0
23 19 1 0
22 24 1 0
13 25 1 1
25 26 1 0
26 27 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 390.51Molecular Weight (Monoisotopic): 390.1838AlogP: 1.99#Rotatable Bonds: 7Polar Surface Area: 117.26Molecular Species: NEUTRALHBA: 8HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.54CX LogP: 0.98CX LogD: 0.92Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.66Np Likeness Score: -1.23
References 1. McGowan DC, Herschke F, Khamlichi MD, Rosauro ML, Benedicto SMP, Pauwels F, Stoops B, Pande V, Scholliers A, Van Schoubroeck B, Mostmans W, Van Dijck K, Thoné T, Horton H, Fanning G, Jonckers THM, Raboisson P.. (2018) Design and synthesis of tetrahydropyridopyrimidine based Toll-Like Receptor (TLR) 7/8 dual agonists., 28 (19): [PMID:30143425 ] [10.1016/j.bmcl.2018.08.015 ]